Navigation Links
Posit Science Featured in New PBS Documentary
Date:11/26/2008

SAN FRANCISCO, Nov. 26 /PRNewswire/ -- Scientists, science and technology from Posit Science(R) Corporation will be featured in a new documentary, entitled "Brain Fitness 2: Sight & Sound," which will begin airing nationwide on PBS stations Thanksgiving weekend.

The program features Dr. Michael Merzenich, Co-founder and Chief Scientist of Posit Science, as well as many other scientific advisors and research collaborators of Posit Science. They discuss recent breakthroughs in brain research and how new technologies can be used to improve lives. For example, the scientists examine how the brain's processing of visual information changes and declines with age. The erosion of sensory processing leads to deficits in mental functions, such as attention and memory, and has other deleterious effects on quality of life. However, new research shows that the brain remains highly plastic, or malleable, and is capable of improving its processing abilities throughout life, when engaged in the right kind of cognitive training activities.

The show will be used in the network's quarterly pledge drives, which raise funds from viewers. It is a sequel to last year's documentary "The Brain Fitness Program." In connection with this year's documentary, major donors to PBS will receive a copy of InSight(TM), the computerized training program from Posit Science designed to improve visual processing and memory.

The Posit Science technology used in InSight has been extensively tested in randomized controlled trials and has been the subject of more than two dozen peer-reviewed articles in science and medical journals. It has been shown effective in increasing visual processing speed, improving driving abilities, and enhancing skills necessary to maintaining independence.

The documentary will first air this weekend and is expected to air throughout the year. Actual times vary by local stations. Local listings can be found at http://www.brainfitness2.com or http://www.positscience.com/pbs along with a preview of the documentary.

About Posit Science:

Posit Science is the leading provider of clinically validated brain fitness programs. The company works with more than 50 scientists from prestigious universities to design and test its computer-based programs. More than 30 published papers show that in randomized controlled trials the company's patented technologies significantly increase processing speed, improve memory and attention, and enhance the quality of everyday life. Posit Science has received grants from the National Institutes of Health and has received numerous awards and accolades. The company's products, scientists and science are currently featured in the PBS documentaries "The Brain Fitness Program" and "Brain Fitness 2: Sight and Sound." For more information, visit http://www.PositScience.com or call 1-866-599-6463.


'/>"/>
SOURCE Posit Science
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genetic predisposition increases childhood asthma risk
2. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
3. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
4. CCRKBA Backs Sen. Coburns Opposition to Tenets of H.R. 327
5. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
6. Nutrition model stresses positive experience of eating
7. Muscle patterns in women may be linked to at risk positioning for ACL tears
8. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
9. Ultrasound plus mammography finds more cancers, but increases false positives
10. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
11. CNS Response, Inc. Appoints George C. Carpenter IV to Position of President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... 22, 2017 , ... The Centers for Medicare & Medicaid ... in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in ... Act of 2015 (MACRA). , This technical assistance, authorized and funded under ...
(Date:2/22/2017)... NJ (PRWEB) , ... February 22, 2017 , ... ... healthcare communications company, launched a new media platform connecting healthcare technology professionals and ... will be followed by a quarterly publication starting on March 1, announced Michael ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. continued ... according to the Association for Pet Obesity Prevention (APOP). During the ninth annual survey, ... such as the benefits of corn and grains, value of raw and organic diets, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... so many different solutions on the market, it is easy to start feeling ... Premier Locksmith offers a complimentary security consultation. , Home Security Hardware Choices, ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017  Bioness, Inc., ... therapies, today announced the first series of successful StimRouter ... at Radboud University Medical Center (Nijmegen, Netherlands ... ( Cork, Ireland ), and Kliniek Park ... the successful launch continuing, Bioness plans to further support ...
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal Therapeutics, ... for both rare and common malignancies, today announced ... financing. The company intends to use the proceeds ... TK216, and to advance preclinical development of a ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody being ...
Breaking Medicine Technology: